메뉴 건너뛰기




Volumn 57, Issue 20, 2014, Pages 8238-8248

Rational use of plasma protein and tissue binding data in drug design

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PROTEIN BINDING;

EID: 84908381840     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm5007935     Document Type: Article
Times cited : (133)

References (64)
  • 1
    • 0242290408 scopus 로고    scopus 로고
    • Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity
    • Valko, K.; Nunhuck, S.; Bevan, C.; Abraham, M. H.; Reynolds, D. P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity J. Pharm. Sci. 2003, 92, 2236-2248
    • (2003) J. Pharm. Sci. , vol.92 , pp. 2236-2248
    • Valko, K.1    Nunhuck, S.2    Bevan, C.3    Abraham, M.H.4    Reynolds, D.P.5
  • 2
    • 33846230530 scopus 로고    scopus 로고
    • Plasma protein binding affinity and its relationship to molecular structure: An in-silico analysis
    • Gleeson, M. P. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis J. Med. Chem. 2007, 50, 101-112
    • (2007) J. Med. Chem. , vol.50 , pp. 101-112
    • Gleeson, M.P.1
  • 4
    • 21444433359 scopus 로고    scopus 로고
    • Strategies to optimize brain penetration in drug discovery
    • Liu, X.; Chen, C. Strategies to optimize brain penetration in drug discovery Curr. Opin. Drug Discovery Dev. 2005, 8, 505-512
    • (2005) Curr. Opin. Drug Discovery Dev. , vol.8 , pp. 505-512
    • Liu, X.1    Chen, C.2
  • 5
    • 34447503927 scopus 로고    scopus 로고
    • The importance of plasma protein binding in drug discovery
    • Trainor, G. The importance of plasma protein binding in drug discovery Expert Opin. Drug Discovery 2007, 2, 51-64
    • (2007) Expert Opin. Drug Discovery , vol.2 , pp. 51-64
    • Trainor, G.1
  • 7
    • 38849136513 scopus 로고    scopus 로고
    • CSF as a surrogate for assessing CNS exposure: An industrial perspective
    • Lin, J. H. CSF as a surrogate for assessing CNS exposure: an industrial perspective Curr. Drug Metab. 2008, 9, 46-59
    • (2008) Curr. Drug Metab. , vol.9 , pp. 46-59
    • Lin, J.H.1
  • 8
    • 76649085489 scopus 로고    scopus 로고
    • Significance of protein binding in pharmacokinetics and pharmacodynamics
    • Schmidt, S.; Gonzalez, D.; Derendorf, H. Significance of protein binding in pharmacokinetics and pharmacodynamics J. Pharm. Sci. 2010, 99, 1107-1122
    • (2010) J. Pharm. Sci. , vol.99 , pp. 1107-1122
    • Schmidt, S.1    Gonzalez, D.2    Derendorf, H.3
  • 9
    • 78649706279 scopus 로고    scopus 로고
    • The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery
    • Smith, D. A.; Di, L.; Kerns, E. H. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery Nat. Rev. Drug Discovery 2010, 9, 929-939
    • (2010) Nat. Rev. Drug Discovery , vol.9 , pp. 929-939
    • Smith, D.A.1    Di, L.2    Kerns, E.H.3
  • 11
    • 0037407697 scopus 로고    scopus 로고
    • Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
    • Banker, M. J.; Clark, T. H.; Williams, J. A. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding J. Pharm. Sci. 2003, 92, 967-974
    • (2003) J. Pharm. Sci. , vol.92 , pp. 967-974
    • Banker, M.J.1    Clark, T.H.2    Williams, J.A.3
  • 12
    • 0035038596 scopus 로고    scopus 로고
    • Development of a high throughput equilibrium dialysis method
    • Kariv, I.; Cao, H.; Oldenburg, K. R. Development of a high throughput equilibrium dialysis method J. Pharm. Sci. 2001, 90, 580-587
    • (2001) J. Pharm. Sci. , vol.90 , pp. 580-587
    • Kariv, I.1    Cao, H.2    Oldenburg, K.R.3
  • 13
    • 0141537961 scopus 로고    scopus 로고
    • Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography-tandem mass spectrometry
    • Fung, E. N.; Chen, Y. H.; Lau, Y. Y. Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography-tandem mass spectrometry J. Chromatogr., B: Anal. Technol. Biomed Life Sci. 2003, 795, 187-194
    • (2003) J. Chromatogr., B: Anal. Technol. Biomed Life Sci. , vol.795 , pp. 187-194
    • Fung, E.N.1    Chen, Y.H.2    Lau, Y.Y.3
  • 14
    • 29044432751 scopus 로고    scopus 로고
    • High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry
    • Wan, H.; Rehngren, M. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry J. Chromatogr., A 2006, 1102, 125-134
    • (2006) J. Chromatogr., A , vol.1102 , pp. 125-134
    • Wan, H.1    Rehngren, M.2
  • 15
    • 17144395222 scopus 로고    scopus 로고
    • Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach
    • Aureli, L.; Cruciani, G.; Cesta, M. C.; Anacardio, R.; De Simone, L.; Moriconi, A. Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach J. Med. Chem. 2005, 48, 2469-2479
    • (2005) J. Med. Chem. , vol.48 , pp. 2469-2479
    • Aureli, L.1    Cruciani, G.2    Cesta, M.C.3    Anacardio, R.4    De Simone, L.5    Moriconi, A.6
  • 16
    • 33845748281 scopus 로고    scopus 로고
    • Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion
    • Wang, J.; Krudy, G.; Xie, X. Q.; Wu, C.; Holland, G. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion J. Chem. Inf. Model. 2006, 46, 2674-2683
    • (2006) J. Chem. Inf. Model. , vol.46 , pp. 2674-2683
    • Wang, J.1    Krudy, G.2    Xie, X.Q.3    Wu, C.4    Holland, G.5
  • 17
    • 2642548329 scopus 로고    scopus 로고
    • Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds
    • Yamazaki, K.; Kanaoka, M. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds J. Pharm. Sci. 2004, 93, 1480-1494
    • (2004) J. Pharm. Sci. , vol.93 , pp. 1480-1494
    • Yamazaki, K.1    Kanaoka, M.2
  • 19
    • 0036874825 scopus 로고    scopus 로고
    • Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery
    • Kalvass, J. C.; Maurer, T. S. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery Biopharm. Drug Dispos. 2002, 23, 327-338
    • (2002) Biopharm. Drug Dispos. , vol.23 , pp. 327-338
    • Kalvass, J.C.1    Maurer, T.S.2
  • 21
    • 0031893997 scopus 로고    scopus 로고
    • Contribution of alpha 1-acid glycoprotein to species difference in lincosamides-plasma protein binding kinetics
    • Son, D. S.; Osabe, M.; Shimoda, M.; Kokue, E. Contribution of alpha 1-acid glycoprotein to species difference in lincosamides-plasma protein binding kinetics J. Vet. Pharmacol. Ther. 1998, 21, 34-40
    • (1998) J. Vet. Pharmacol. Ther. , vol.21 , pp. 34-40
    • Son, D.S.1    Osabe, M.2    Shimoda, M.3    Kokue, E.4
  • 22
    • 0034935629 scopus 로고    scopus 로고
    • Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolites
    • Endo, H.; Yoshida, H.; Hasegawa, M.; Ohmi, N.; Horiuchi, N.; Hamada, Y.; Higuchi, S. Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolites Biol. Pharm. Bull. 2001, 24, 800-805
    • (2001) Biol. Pharm. Bull. , vol.24 , pp. 800-805
    • Endo, H.1    Yoshida, H.2    Hasegawa, M.3    Ohmi, N.4    Horiuchi, N.5    Hamada, Y.6    Higuchi, S.7
  • 23
    • 70349557614 scopus 로고    scopus 로고
    • Enantioselective plasma protein binding of propafenone: Mechanism, drug interaction, and species difference
    • Hong, Y.; Tang, Y.; Zeng, S. Enantioselective plasma protein binding of propafenone: mechanism, drug interaction, and species difference Chirality 2009, 21, 692-698
    • (2009) Chirality , vol.21 , pp. 692-698
    • Hong, Y.1    Tang, Y.2    Zeng, S.3
  • 24
    • 53149121998 scopus 로고    scopus 로고
    • Cross-species differential plasma protein binding of MBX-102/JNJ39659100: A novel PPAR-gamma agonist
    • Clarke, H. J.; Gregoire, F.; Ma, F.; Martin, R.; Zhao, S.; Lavan, B. E. Cross-species differential plasma protein binding of MBX-102/JNJ39659100: a novel PPAR-gamma agonist PPAR Res. 2008, 2008, 1-10
    • (2008) PPAR Res. , vol.2008 , pp. 1-10
    • Clarke, H.J.1    Gregoire, F.2    Ma, F.3    Martin, R.4    Zhao, S.5    Lavan, B.E.6
  • 28
    • 34548071206 scopus 로고    scopus 로고
    • In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids
    • Friden, M.; Gupta, A.; Antonsson, M.; Bredberg, U.; Hammarlund-Udenaes, M. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids Drug Metab. Dispos. 2007, 35, 1711-1719
    • (2007) Drug Metab. Dispos. , vol.35 , pp. 1711-1719
    • Friden, M.1    Gupta, A.2    Antonsson, M.3    Bredberg, U.4    Hammarlund-Udenaes, M.5
  • 30
    • 84878631164 scopus 로고    scopus 로고
    • Rapid measurement of intracellular unbound drug concentrations
    • Mateus, A.; Matsson, P.; Artursson, P. Rapid measurement of intracellular unbound drug concentrations Mol. Pharmaceutics 2013, 10, 2467-2478
    • (2013) Mol. Pharmaceutics , vol.10 , pp. 2467-2478
    • Mateus, A.1    Matsson, P.2    Artursson, P.3
  • 31
    • 84886533717 scopus 로고    scopus 로고
    • Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue
    • Pfeifer, N. D.; Harris, K. B.; Yan, G. Z.; Brouwer, K. L. Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue Drug Metab. Dispos. 2013, 41, 1949-1956
    • (2013) Drug Metab. Dispos. , vol.41 , pp. 1949-1956
    • Pfeifer, N.D.1    Harris, K.B.2    Yan, G.Z.3    Brouwer, K.L.4
  • 32
    • 0018190444 scopus 로고
    • Hepatic elimination of flowing substrates: The distributed model
    • Bass, L.; Robinson, P.; Bracken, A. J. Hepatic elimination of flowing substrates: the distributed model J. Theor. Biol. 1978, 72, 161-184
    • (1978) J. Theor. Biol. , vol.72 , pp. 161-184
    • Bass, L.1    Robinson, P.2    Bracken, A.J.3
  • 33
    • 0017603437 scopus 로고
    • Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
    • Pang, K. S.; Rowland, M. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance J. Pharmacokinet. Biopharm. 1977, 5, 625-653
    • (1977) J. Pharmacokinet. Biopharm. , vol.5 , pp. 625-653
    • Pang, K.S.1    Rowland, M.2
  • 34
    • 0017603438 scopus 로고
    • Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation
    • Pang, K. S.; Rowland, M. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation J. Pharmacokinet. Biopharm. 1977, 5, 655-680
    • (1977) J. Pharmacokinet. Biopharm. , vol.5 , pp. 655-680
    • Pang, K.S.1    Rowland, M.2
  • 35
    • 0017565370 scopus 로고
    • Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation
    • Pang, K. S.; Rowland, M. Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation J. Pharmacokinet. Biopharm. 1977, 5, 681-699
    • (1977) J. Pharmacokinet. Biopharm. , vol.5 , pp. 681-699
    • Pang, K.S.1    Rowland, M.2
  • 36
    • 0022549973 scopus 로고
    • A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations
    • Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations J. Pharmacokinet. Biopharm. 1986, 14, 227-260
    • (1986) J. Pharmacokinet. Biopharm. , vol.14 , pp. 227-260
    • Roberts, M.S.1    Rowland, M.2
  • 37
    • 0022552317 scopus 로고
    • A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity
    • Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity J. Pharmacokinet. Biopharm. 1986, 14, 261-288
    • (1986) J. Pharmacokinet. Biopharm. , vol.14 , pp. 261-288
    • Roberts, M.S.1    Rowland, M.2
  • 38
    • 0022922022 scopus 로고
    • A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics
    • Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics J. Pharmacokinet. Biopharm. 1986, 14, 289-308
    • (1986) J. Pharmacokinet. Biopharm. , vol.14 , pp. 289-308
    • Roberts, M.S.1    Rowland, M.2
  • 39
    • 0018163388 scopus 로고
    • Hepatic transport kinetics and plasma disappearance curves: Distributed modeling versus conventional approach
    • Forker, E. L.; Luxon, B. Hepatic transport kinetics and plasma disappearance curves: distributed modeling versus conventional approach Am. J. Physiol. 1978, 235, E648-E660
    • (1978) Am. J. Physiol. , vol.235 , pp. 648-E660
    • Forker, E.L.1    Luxon, B.2
  • 40
    • 77949821065 scopus 로고    scopus 로고
    • On the influence of protein binding on pharmacological activity of drugs
    • Berezhkovskiy, L. M. On the influence of protein binding on pharmacological activity of drugs J. Pharm. Sci. 2010, 99, 2153-2165
    • (2010) J. Pharm. Sci. , vol.99 , pp. 2153-2165
    • Berezhkovskiy, L.M.1
  • 42
    • 79551662332 scopus 로고    scopus 로고
    • Do we need to optimize plasma protein and tissue binding in drug discovery?
    • Liu, X.; Chen, C.; Hop, C. E. Do we need to optimize plasma protein and tissue binding in drug discovery? Curr. Top Med. Chem. 2011, 11, 450-466
    • (2011) Curr. Top Med. Chem. , vol.11 , pp. 450-466
    • Liu, X.1    Chen, C.2    Hop, C.E.3
  • 43
    • 0021361240 scopus 로고
    • Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding
    • Jones, D. B.; Morgan, D. J.; Mihaly, G. W.; Webster, L. K.; Smallwood, R. A. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding J. Pharmacol. Exp. Ther. 1984, 229, 522-526
    • (1984) J. Pharmacol. Exp. Ther. , vol.229 , pp. 522-526
    • Jones, D.B.1    Morgan, D.J.2    Mihaly, G.W.3    Webster, L.K.4    Smallwood, R.A.5
  • 44
    • 0023682627 scopus 로고
    • Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: Comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models
    • Smallwood, R. H.; Morgan, D. J.; Mihaly, G. W.; Jones, D. B.; Smallwood, R. A. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models J. Pharmacokinet. Biopharm. 1988, 16, 377-396
    • (1988) J. Pharmacokinet. Biopharm. , vol.16 , pp. 377-396
    • Smallwood, R.H.1    Morgan, D.J.2    Mihaly, G.W.3    Jones, D.B.4    Smallwood, R.A.5
  • 45
    • 0018750411 scopus 로고
    • Albumin-deficient rat mutant
    • Nagase, S.; Shimamune, K.; Shumiya, S. Albumin-deficient rat mutant Science 1979, 205, 590-591
    • (1979) Science , vol.205 , pp. 590-591
    • Nagase, S.1    Shimamune, K.2    Shumiya, S.3
  • 46
    • 48849115495 scopus 로고    scopus 로고
    • Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR)
    • Miida, H.; Arakawa, S.; Shibaya, Y.; Honda, K.; Kiyosawa, N.; Watanabe, K.; Manabe, S.; Takasaki, W.; Ueno, K. Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR) J. Toxicol. Sci. 2008, 33, 349-361
    • (2008) J. Toxicol. Sci. , vol.33 , pp. 349-361
    • Miida, H.1    Arakawa, S.2    Shibaya, Y.3    Honda, K.4    Kiyosawa, N.5    Watanabe, K.6    Manabe, S.7    Takasaki, W.8    Ueno, K.9
  • 47
    • 33845899457 scopus 로고    scopus 로고
    • Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-chloro-4-[ N -(2-methylphenyl)-ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidine-2-yl]-methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism
    • Ito, T.; Takahashi, M.; Sudo, K.; Sugiyama, Y. Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-chloro-4-[ N -(2-methylphenyl)-ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidine-2-yl]-methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism J. Pharmacol. Exp. Ther. 2007, 320, 124-132
    • (2007) J. Pharmacol. Exp. Ther. , vol.320 , pp. 124-132
    • Ito, T.1    Takahashi, M.2    Sudo, K.3    Sugiyama, Y.4
  • 48
    • 0036218554 scopus 로고    scopus 로고
    • Changes in plasma protein binding have little clinical relevance
    • Benet, L. Z.; Hoener, B. A. Changes in plasma protein binding have little clinical relevance Clin. Pharmacol. Ther. 2002, 71, 115-121
    • (2002) Clin. Pharmacol. Ther. , vol.71 , pp. 115-121
    • Benet, L.Z.1    Hoener, B.A.2
  • 49
    • 0036799286 scopus 로고    scopus 로고
    • The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics
    • Toutain, P. L.; del Castillo, J. R.; Bousquet-Melou, A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics Res. Vet. Sci. 2002, 73, 105-114
    • (2002) Res. Vet. Sci. , vol.73 , pp. 105-114
    • Toutain, P.L.1    Del Castillo, J.R.2    Bousquet-Melou, A.3
  • 50
    • 0031442434 scopus 로고    scopus 로고
    • Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat
    • Blakey, G. E.; Nestorov, I. A.; Arundel, P. A.; Aarons, L. J.; Rowland, M. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat J. Pharmacokinet. Biopharm. 1997, 25, 277-312
    • (1997) J. Pharmacokinet. Biopharm. , vol.25 , pp. 277-312
    • Blakey, G.E.1    Nestorov, I.A.2    Arundel, P.A.3    Aarons, L.J.4    Rowland, M.5
  • 51
    • 46449114275 scopus 로고    scopus 로고
    • Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
    • Obach, R. S.; Lombardo, F.; Waters, N. J. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds Drug Metab. Dispos. 2008, 36, 1385-1405
    • (2008) Drug Metab. Dispos. , vol.36 , pp. 1385-1405
    • Obach, R.S.1    Lombardo, F.2    Waters, N.J.3
  • 52
    • 0001394264 scopus 로고
    • Apparent volume of distribution
    • In, 2 nd ed. Marcel Dekker: New York, Vol.
    • Gibaldi, M.; Perrier, D. Apparent volume of distribution. In Pharmacokinetics, 2 nd ed.; Marcel Dekker: New York, 1982; Vol. 15, pp 199-219.
    • (1982) Pharmacokinetics , vol.15 , pp. 199-219
    • Gibaldi, M.1    Perrier, D.2
  • 53
    • 1242273811 scopus 로고    scopus 로고
    • Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics
    • Lombardo, F.; Obach, R. S.; Shalaeva, M. Y.; Gao, F. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics J. Med. Chem. 2004, 47, 1242-1250
    • (2004) J. Med. Chem. , vol.47 , pp. 1242-1250
    • Lombardo, F.1    Obach, R.S.2    Shalaeva, M.Y.3    Gao, F.4
  • 54
    • 0037142338 scopus 로고    scopus 로고
    • Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data
    • Lombardo, F.; Obach, R. S.; Shalaeva, M. Y.; Gao, F. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data J. Med. Chem. 2002, 45, 2867-2876
    • (2002) J. Med. Chem. , vol.45 , pp. 2867-2876
    • Lombardo, F.1    Obach, R.S.2    Shalaeva, M.Y.3    Gao, F.4
  • 55
    • 0029160004 scopus 로고
    • Effective half-life in clinical pharmacology
    • Boxenbaum, H.; Battle, M. Effective half-life in clinical pharmacology J. Clin. Pharmacol. 1995, 35, 763-766
    • (1995) J. Clin. Pharmacol. , vol.35 , pp. 763-766
    • Boxenbaum, H.1    Battle, M.2
  • 56
    • 72449185642 scopus 로고    scopus 로고
    • Addressing central nervous system (CNS) penetration in drug discovery: Basics and implications of the evolving new concept
    • Reichel, A. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept Chem. Biodiversity 2009, 6, 2030-2049
    • (2009) Chem. Biodiversity , vol.6 , pp. 2030-2049
    • Reichel, A.1
  • 57
    • 42449100856 scopus 로고    scopus 로고
    • Progress in brain penetration evaluation in drug discovery and development
    • Liu, X.; Chen, C.; Smith, B. J. Progress in brain penetration evaluation in drug discovery and development J. Pharmacol. Exp. Ther. 2008, 325, 349-356
    • (2008) J. Pharmacol. Exp. Ther. , vol.325 , pp. 349-356
    • Liu, X.1    Chen, C.2    Smith, B.J.3
  • 58
    • 84872319925 scopus 로고    scopus 로고
    • Demystifying brain penetration in central nervous system drug discovery
    • Di, L.; Rong, H.; Feng, B. Demystifying brain penetration in central nervous system drug discovery J. Med. Chem. 2013, 56, 2-12
    • (2013) J. Med. Chem. , vol.56 , pp. 2-12
    • Di, L.1    Rong, H.2    Feng, B.3
  • 59
    • 63349088174 scopus 로고    scopus 로고
    • Methodologies to assess brain drug delivery in lead optimization
    • Hammarlund-Udenaes, M.; Bredberg, U.; Friden, M. Methodologies to assess brain drug delivery in lead optimization Curr. Top Med. Chem. 2009, 9, 148-162
    • (2009) Curr. Top Med. Chem. , vol.9 , pp. 148-162
    • Hammarlund-Udenaes, M.1    Bredberg, U.2    Friden, M.3
  • 60
    • 0030898087 scopus 로고    scopus 로고
    • Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method
    • Hammarlund-Udenaes, M.; Paalzow, L. K.; de Lange, E. C. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method Pharm. Res. 1997, 14, 128-134
    • (1997) Pharm. Res. , vol.14 , pp. 128-134
    • Hammarlund-Udenaes, M.1    Paalzow, L.K.2    De Lange, E.C.3
  • 61
    • 11144290156 scopus 로고    scopus 로고
    • Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice
    • Maurer, T. S.; Debartolo, D. B.; Tess, D. A.; Scott, D. O. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice Drug Metab. Dispos. 2005, 33, 175-181
    • (2005) Drug Metab. Dispos. , vol.33 , pp. 175-181
    • Maurer, T.S.1    Debartolo, D.B.2    Tess, D.A.3    Scott, D.O.4
  • 63
    • 33644756715 scopus 로고    scopus 로고
    • Improving the in vitro prediction of in vivo central nervous system penetration: Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
    • Summerfield, S. G.; Stevens, A. J.; Cutler, L.; del Carmen Osuna, M.; Hammond, B.; Tang, S. P.; Hersey, A.; Spalding, D. J.; Jeffrey, P. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain J. Pharmacol. Exp. Ther. 2006, 316, 1282-1290
    • (2006) J. Pharmacol. Exp. Ther. , vol.316 , pp. 1282-1290
    • Summerfield, S.G.1    Stevens, A.J.2    Cutler, L.3    Del Carmen Osuna, M.4    Hammond, B.5    Tang, S.P.6    Hersey, A.7    Spalding, D.J.8    Jeffrey, P.9
  • 64
    • 67649408864 scopus 로고    scopus 로고
    • Unbound brain concentration determines receptor occupancy: A correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats
    • Liu, X.; Vilenski, O.; Kwan, J.; Apparsundaram, S.; Weikert, R. Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats Drug Metab. Dispos. 2009, 37, 1548-1556
    • (2009) Drug Metab. Dispos. , vol.37 , pp. 1548-1556
    • Liu, X.1    Vilenski, O.2    Kwan, J.3    Apparsundaram, S.4    Weikert, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.